Zydus Cadila has received the final approval from the USFDA to market Acetazolamide ER Capsules (US RLD Diamox).
It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.
Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used to treat certain types of glaucoma (caused by increased ocular pressure) and to treat or prevent altitude sickness (acute mountain sickness).
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)